The Feasibility and Application of Intraoperative Ultrasound to Evaluate Femoral Head Shaping

July 18, 2021 updated by: Cui Ligang, Peking University Third Hospital
To assess the feasibility of using intraoperative ultrasound to evaluate the femoral head formation; to evaluate the improvement of the forming effect using the intraoperative ultrasound combined with c-arm.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Ultrasound can provide a multi-directional scan of the femoral head and neck junction, and the range of evaluation is larger than that of the intraoperative c-arm. The study was to assess the feasibility of using intraoperative ultrasound to evaluate the femoral head formation; to evaluate the forming of the femoral head and the improvement of the forming effect using the intraoperative ultrasound combined with c-arm.

Study Type

Observational

Enrollment (Actual)

78

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100191
        • Peking Univesity Third Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

According to the sequential test, the enrolled patients were divided into ultrasound evaluation group and no ultrasound evaluation group. Inclusion Criteria included patients with hip pain; Cam type (alpha Angle > 50°) impingement and glenoid labrum laceration.

Description

Inclusion Criteria:

  • Patients with hip pain;
  • Cam type (alpha Angle > 50°) impingement and glenoid labrum laceration

Exclusion Criteria:

  • Previous hip surgery;
  • Patients with subosseous cystic degeneration of synovitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Ultrasonic and c-arm combination group
Ultrasound and c-arm were combined to evaluate intraoperatively conditions
According to the sequential test, the enrolled patients were divided into ultrasound evaluation group and no ultrasound evaluation group.
c-arm group
c-arm group was used to evaluate intraoperatively conditions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS scale
Time Frame: 1 year after operation
Visual analogue scale(VAS)was used to measure the pain score. The minimum and maximum values were 0 and 10. The higher score, the worse pain.
1 year after operation
MHHS scale
Time Frame: 1 year after operation
Modified Harris Hip Score (MHHS) scale was used to measure the symptoms of joint. The minimum and maximum values were 0 and 91. The higher score, the better.
1 year after operation
Hip CT
Time Frame: 1 day after operation
Routine postoperative hip CT was used to understand the joint morphology.
1 day after operation
Hip X-ray
Time Frame: 1 day after operation
Routine hip X-ray at the Dunn position was conducted.
1 day after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cui Ligang, Peking University Third Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

May 1, 2019

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

July 2, 2021

First Submitted That Met QC Criteria

July 18, 2021

First Posted (Actual)

July 28, 2021

Study Record Updates

Last Update Posted (Actual)

July 28, 2021

Last Update Submitted That Met QC Criteria

July 18, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • M2019453

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Femoroacetabular Impingement

Clinical Trials on ultrasound evaluation

3
Subscribe